The Main Early Clinical Features of Kawasaki Disease Shock Syndrome and Septic Shock in Children:a Comparative Study
Department of PICU,Hebei Children's Hospital Affiliated to Hebei Medical University,Shijiazhuang 050000,China
*Corresponding author:XU Meixian,Chief physician,Master supervisor;E-mail:xumeixian2019@163.com
XU Meixian,LIU Gang,CAO Lijing, et al. The Main Early Clinical Features of Kawasaki Disease Shock Syndrome and Septic Shock in Children:a Comparative Study [J]. Chinese General Practice, 2020, 23(30): 3812-3816. DOI: 10.12114/j.issn.1007-9572.2020.00.250.
徐梅先,刘刚,曹利静等. 儿童川崎病休克综合征与脓毒性休克早期主要临床特征的对比研究[J]. 中国全科医学, 2020, 23(30): 3812-3816. DOI: 10.12114/j.issn.1007-9572.2020.00.250.
[1]KATO H,SUGIMURA T,AKAGI T,et al.Long-term consequences of Kawasaki disease.A 10- to 21-year follow-up study of 594 patients[J].Circulation,1996,94(6):1379-1385.DOI:10.1161/01.cir.94.6.1379.
[2]HA K S,JANG G,LEE J,et al.Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease:a meta-analysis[J].Eur J Pediatr,2013,172(3):343-349.DOI:10.1007/s00431-012-1891-5.
[3]KANEGAYE J T,WILDER M S,MOLKARA D,et al.Recognition of a Kawasaki disease shock syndrome[J].Pediatrics,2009,123(5):e783-789.DOI:10.1542/peds.2008-1871.
[4]《中华儿科杂志》编辑委员会,中华医学会儿科学分会心血管学组,中华医学会儿科学分会免疫学组.川崎病专题讨论会纪要[J].中华儿科杂志,2007,45(11):826-830.DOI:10.3760/j.issn:0578-1310.2007.11.007.
[5]DELLINGER R P,LEVY M M,RHODES A,et al.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock:2012[J].Crit Care Med,2013,41(2):580-637.DOI:10.1097/CCM.0b013e31827e83af.
[6]GOLDSTEIN B,GIROIR B,RANDOLPH A,et al.International pediatric sepsis consensus conference:definitions for sepsis and organ dysfunction in pediatrics[J].Pediatr Crit Care Med,2005,6(1):2-8.DOI:10.1097/01.PCC.0000149131.72248.E6.
[7]LAPPIN E,FERGUSON A J.Gram-positive toxic shock syndromes[J].Lancet Infect Dis,2009,9(5):281-290.DOI:10.1016/S1473-3099(09)70066-0.
[8]LAMAGNI T L,DARENBERG J,LUCA-HARARI B,et al.
Epidemiology of severe Streptococcus pyogenes disease in Europe[J].J Clin Microbiol,2008,46(7):2359-2367.DOI:10.1128/JCM.00422-08.
[9]ESPER A M,MOSS M,LEWIS C A,et al.The role of infection and comorbidity:factors that influence disparities in sepsis[J].Crit Care Med,2006,34(10):2576-2582.DOI:10.1097/01.CCM.0000239114.50519.0E.
[10]商娜.脓毒症流行病学研究[J].中国急救医学,2013,33(1):8-12.DOI:10.3969/j.issn.1002-1949.2013.1.003.
SHANG N.Research on the epidemiology of sepsis[J].Chinese Journal of Critical Care Medicine,2013,33(1):8-12.DOI:10.3969/j.issn.1002-1949.2013.1.003.
[11]MA L,ZHANG Y Y,YU H G.Clinical manifestations of Kawasaki disease shock syndrome[J].Clin Pediatr (Phila),2018,57(4):428-435.DOI:10.1177/0009922817729483.
[12]DOMINGUEZ S R,FRIEDMAN K,SEEWALD R,et al.Kawasaki disease in a pediatric intensive care unit:a case-control study[J].Pediatrics,2008,122(4):e786-790.DOI:10.1542/peds.2008-1275.
[13]BURNS J C,GLODE M P.Kawasaki syndrome[J].Lancet,2004,364:533-544.DOI:10.1016/S0140-6736(04)16814-1.
[14]KLIEGMAN R,STANTON B,GEME J,et al.Nelson Textbook of Pediatric[M].20th Edition.Amsterdam:Slsevier,2005.
[15]齐颖,武宇辉,杨燕澜,等.16例川崎病休克综合征临床分析[J].中国小儿急救医学,2017,24(12):925-928.DOI:10.3760/cma.j.issn.1673-4912.2017.12.012.
QI Y,WU Y H,YANG Y L,et al.Clinical manifestations of 16 cases with Kawasaki disease shock syndrome[J].Chinese Pediatric Emergency Medicine,2017,24(12):925-928.DOI:10.3760/cma.j.issn.1673-4912.2017.12.012.
[16]KUO H C,YANG Y L,CHUANG J H,et al.Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease[J].J Clin Immunol,2012,32(4):746-752.DOI:10.1007/s10875-012-9668-1.
[17]李娟珍,王莹.PICU中儿童脓毒症临床特点和预后相关因素分析[J].临床儿科杂志,2017,35(10):762-768.DOI:10.3969/j.issn.1000-3606.2017.10.012.
LI J Z,WANG Y.Analysis of clinical characteristics and prognostic factors of childhood sepsis in pediatric intensive care unit[J].Journal of Clinical Pediatrics,2017,35(10):762-768.DOI:10.3969/j.issn.1000-3606.2017.10.012.
[18]张明明,石琳,李晓惠,等.川崎休克综合征11例临床分析[J].中国临床医生杂志,2017,45(9):98-100.DOI:10.3969/j.issn.2095-8552.2017.09.037.
[19]THABET F,BAFAQIH H,AL-MOHAIMEED S,et al.Shock:an unusual presentation of Kawasaki disease[J].Eur J Pediatr,2011,170(7):941-943.DOI:10.1007/s00431-011-1426-5.
[20]陈莉琼.川崎病休克综合征误诊为脓毒性休克1例报告[J].中国实用儿科杂志,2017,32(11):876-877.DOI:10.19538/j.ek2017110617.
[21]NATTERER J,PEREZ M H,DI BERNARDO S.Capillary leak leading to shock in Kawasaki disease without myocardial dysfunction[J].Cardiol Young,2012,22(3):349-352.DOI:10.1017/S1047951111001314.
[22]ONOUCHI Z,HAMAOKA K,OZAWA S,et al.Neutropenia in the acute phase of Kawasaki disease and prevention of coronary artery aneurysm[J].Pediatr Int,2009,51(4):448-452.DOI:10.1111/j.1442-200X.2008.02789.x.
[23]GATTERRE P,OUALHA M,DUPIC L,et al.Kawasaki disease:an unexpected etiology of shock and multiple organ dysfunction syndrome[J].Intensive Care Med,2012,38(5):872-878.DOI:10.1007/s00134-012-2473-8.
[24]GáMEZ-GONZáLEZ L B,MURATA C,MU?OZ-RAMíREZ M,et al.Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children[J].Eur J Pediatr,2013,172(3):337-342.DOI:10.1007/s00431-012-1879-1.
[25]MELENDEZ E,BACHUR R.Advances in the emergency management of pediatric sepsis[J].Curr Opin Pediatr,2006,18(3):245-253.DOI:10.1097/01.mop.0000193305.55635.ff.
[26]LODHA R,ARUN S,VIVEKANANDHAN S,et al.Myocardial cell injury is common in children with septic shock[J].Acta Paediatr,2009,98(3):478-481.DOI:10.1111/j.1651-2227.2008.01095.x.
[27]BRIASSOULIS G,NARLIOGLOU M,ZAVRAS N,et al.Myocardial injury in meningococcus-induced purpura fulminans in children[J].Intensive Care Med,2001,27(6):1073-1082.DOI:10.1007/s001340100957.
[28]FENTON K E,SABLE C A,BELL M J,et al.Increases in serum levels of troponin I are associated with cardiac dysfunction and disease severity in pediatric patients with septic shock[J].Pediatr Crit Care Med,2004,5(6):533-538.DOI:10.1097/01.PCC.0000144711.97646.0C.
[29]GACH O,LANCELLOTTI P,PIERARD L A.Acute ST-segment elevation in Neisseria meningitis[J].Acta Cardiol,2001,56(5):327-329.DOI:10.2143/AC.56.5.2005695.
LI J P,GUO X H,ZHENG Y Y,et al.Association between Arg389Gly beta1-adrenergic receptor polymorphisms and essential hypertension[J].International Journal of Cardiovascular Disease,2006,33(4):275-277.